Influence of TNF gene polymorphism and HLA-DRB1 haplotype in Japanese patients with chronic liver disease caused by HCV

American Journal of Gastroenterology

Volumn 98, Issue 1, 2003, Pages 160-166

  Tokushige, Katsutoshi ^a,b   Tsuchiya, Noriko ^a,b   Hasegawa, Kiyoshi ^a,b   Hashimoto, Etsuko ^a,b   Yamauchi, Katsumi ^a,b   Komatsu, Tatsuzi ^a,b   Hayashi, Naoaki ^a,b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b YOKOHAMA NATIONAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HLA DR ANTIGEN; INTERFERON; NEOMINOPHAGEN C; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENETIC ANALYSIS; HAPLOTYPE; HEPATITIS C; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; JAPAN; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROMOTER REGION;

FEMALE; HAPLOTYPES; HEPATITIS C, CHRONIC; HLA-DR ANTIGENS; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037253747     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07177.x     Document Type: Article

References (29)

1. Yamada M, Kakumu S, Yoshioka K, et al. Hepatitis C virus genotypes are not responsible for development of serious liver disease. Dig Dis Sci 1994;39:234-9.
2. McGuinness PH, Bishop GA, Painter DM, et al. Intra-hepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis. Hepatology 1996;23:676-87.
3. Tilg H, Wilmer A, Vogel W, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264-73.
4. Torre D, Zeroli C, Giola M, et al. Serum levels of interleukin-1α, interleukin-1β, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis. Clin Infect Dis 1994;18:194-8.
5. Lohr HF, Schlaak JF, Gerken G, et al. Phenotypical analysis and cytokine release of liver-infiltrating and peripheral blood T lymphocytes from patients with chronic hepatitis of different etiology. Liver 1994;14:161-6.
6. Koziel MJ, Dudley D, Afdhal N, et al. HLA class-I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release. J Clin Invest 1995;96:2311-21.
7. Gonzalez-Amaro R, Garcia-Mozon C, Garcia-Buey L, et al. Induction of tumor necrosis factor-a production by human hepatocytes in chronic viral hepatitis. J Exp Med 1994;179:841-8.
8. Larrea E, Garcia N, Qian C, et al. Tumor necrosis factor alpha gene expression and the response to interferon in chronic hepatitis C. Hepatology 1996;23:210-7.
9. Wilson A, Giovine FD, Duff G. Genetics of TNFα in auto-immune, infectious and neoplastic diseases. J Inflamm 1995; 45:1-12.
10. Pociot F, Briant L, Jongeneel CV, et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility alleles with the secretion of TNF alpha and TNF beta by human mononuclear cells; a possible link to insulin dependent diabetes mellitus. Eur J Immunol 1993;23:224-31.
11. McGuire W, Hill AVS, Allsopp CE, et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
12. McGuire W, Knight JC, Hill AVS, et al. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J Infect Dis 1999;179:287-90.
13. Wilson AG, Symons JA, McDowell TL, et al. Effect of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
14. Hohler T, Kruger A, Gerkan G, et al. Tumor necrosis factor alpha promoter polymorphsim at position -238 associated with chronic active hepatitis. J Med Virol 1998;54:173-7.
15. Yee LJ, Tang J, Herrera J, et al. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Gene Immun 2000;1:386-90.
16. Kuzushita N, Hayashi N, Moribe T, et al. Influence of HLA haplotypes on clinical courses of individuals infected with hepatitis C virus. Hepatology 1998;27:240-4.
17. Aikawa T, Kojima M, Onishi H, et al. HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatic C. J Med Virol 1996;49:274-8.
18. Kaneshige T, Takagi K, Nakamura S, et al. Genomic analysis using fingernail DNA. Nucl Acids Res 1992;20:5489-90.
19. Bernal W, Donaldson P, Underhill J, et al. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracentamol)-induced acute liver failure. J Hepatol 1998;29:53-9.
20. Wilson AG, di Giovine FS, Blakemore AIF, et al. Single base polymorphism in the human tumor necrosis factor alpha gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
21. Gordon MA, Oppenheim E, Camp NJ, et al. Primary biliary cirrhosis shows association with genetic polymorphism of tumor necrosis factor alpha promoter region. J Hepatol 1999; 31:242-7.
22. Kaneshige T, Hashimoto M, Matsumoto Y, et al. Serologic and nucleotide sequencing analyses of a novel DR52-associated DRB1 allele with the DR' NJ25' specificity, designated DRB1*1307. Hum Immunol 1994;41:151-9.
23. Moribe T, Kaneshige T, Hirakata M, et al. Identification of DRB1*0405 variant (DRB1*04052) using the PCR-RFLP method. Tissue Antigens 1996;47:450-3.
24. Negoro K, Kinouchi Y, Hiwatashi N, et al. Crohn's disease is associated with novel polymorphisms in the 5′-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;117:1062-8.
25. Louis E, Peeters D, Frachimont L, et al. Tumor necrosis factor (TNF) gene polymorphism in Crohn's disease (CD) influence on disease behaviour?. Clin Exp Immunol 2000;119:64-8.
26. Persico M, Persico E, Supzzo R, et al. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels. Gastroenterology 2000;118:760-4.
27. Kuzushita N, Hayashi N, Katayama K, et al. Increased frequency of HLA DR13 in hepatitis C virus carriers with persistently normal ALT levels. J Med Virol 1996;48:1-7.
28. Stuber F, Petersen M, Bokelmann F, et al. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-α concentrations and outcome of patients with severe sepsis. Crit Care Med 1996;24:381-4.
29. Bettinotti MP, Hartung K, Deicher H, et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 1993;37:449-54.